Abd Alhasan
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- Extracellular vesicles in disease
- RNA Research and Splicing
- RNA modifications and cancer
Papers in
-
- Circular RNAs in diseases 2
- Angiogenesis and VEGF in Cancer 1
- Fibroblast Growth Factor Research 1
-
- Platelet Disorders and Treatments 2
- Co-authors
- David J. Elliott (3 shared papers)Mauro Santibanez‐Koref (3 shared papers)Michael S. Jackson (3 shared papers)Osagie Izuogu (3 shared papers)Lamin Marenah (1 shared paper)Joanne C. Mountford (1 shared paper)Cédric Ghevaert (1 shared paper)Maria Colzani (1 shared paper)
- Journals
- Blood (1 paper)BMC Genomics (1 paper)Journal of Leukocyte Biology (1 paper)Journal of Biological Chemistry (1 paper)BMC Bioinformatics (1 paper)
- Partner nations
- United KingdomNorwaySaudi Arabia
In The Last Decade
Abd Alhasan
5 papers receiving 296 citations
Peers
Comparison fields: 5 of 34
- Cancer Research 189
- Molecular Biology 237
- Hematology 28
- Internal Medicine 6
- Immunology and Allergy 6
Countries citing papers authored by Abd Alhasan
This map shows the geographic impact of Abd Alhasan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abd Alhasan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abd Alhasan more than expected).
Fields of papers citing papers by Abd Alhasan
This network shows the impact of papers produced by Abd Alhasan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abd Alhasan. The network helps show where Abd Alhasan may publish in the future.
Co-authors
The 25 scholars most cited alongside Abd Alhasan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 179 | |
| 2 | 2016 | 49 | |
| 3 | 2018 | 39 | |
| 4 | 2014 | 23 | |
| 5 | 2012 | 7 |
About Abd Alhasan
Abd Alhasan is a scholar working on Molecular Biology, Hematology, Cell Biology, Immunology and Allergy and Cancer Research, having authored 5 papers that have together received 297 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (2 papers), Circular RNAs in diseases (2 papers), Cell Adhesion Molecules Research (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Proteoglycans and glycosaminoglycans research (1 paper), MicroRNA in disease regulation (1 paper), Cancer-related molecular mechanisms research (1 paper) and Fibroblast Growth Factor Research (1 paper). The work is most often cited by research in Cancer Research (189 citations), Molecular Biology (237 citations), Hematology (28 citations), Internal Medicine (6 citations) and Immunology and Allergy (6 citations). Abd Alhasan has collaborated with scholars based in United Kingdom, Norway and Saudi Arabia. Frequent co-authors include David J. Elliott, Mauro Santibanez‐Koref, Michael S. Jackson, Osagie Izuogu, Lamin Marenah, Joanne C. Mountford, Cédric Ghevaert, Maria Colzani, Haya H. Al‐Balool and Jannetta S. Steyn. Their work appears in journals such as Blood, BMC Genomics, Journal of Leukocyte Biology, Journal of Biological Chemistry and BMC Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.